This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaidi, M. B.
Right arrow Articles by Headrick, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaidi, M. B.
Right arrow Articles by Headrick, M. L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2003, p. 1999-2001, Vol. 47, No. 6
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.6.1999-2001.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Risk Factors for Fecal Quinolone-Resistant Escherichia coli in Mexican Children

Mussaret B. Zaidi,1* Emma Zamora,1 Pilar Diaz,1 Linda Tollefson,2 Paula J. Fedorka-Cray,3 and Marcia L. Headrick2

Laboratorio de Investigación, Hospital General O'Horan, Mérida, Yucatan, Mexico,1 Center for Veterinary Medicine, Food and Drug Administration, Rockville, Maryland,2 Antimicrobial Resistance Research Unit, Agricultural Research Service, USDA Russell Research Center, Athens, Georgia3

Received 26 August 2002/ Returned for modification 19 November 2002/ Accepted 20 February 2003

We determined the prevalence of, and risk factors for, fecal quinolone-resistant Escherichia coli (QREC) in 324 children from Yucatan, Mexico. QREC was higher in children with recent Salmonella infection (100%) than in children with diarrhea (61%) or healthy children (54%) (P = 0.007). Multivariate analysis identified recent hospitalization of a family member (P = 0.011, odds ratio [OR] = 5.1) and carriage of Salmonella (P = 0.004, OR = 3.7) as independent risk factors for QREC.


* Corresponding author. Mailing address: Laboratorio de Investigación, Hospital General O'Horan, Av. Itzaes x Jacinto Canek, Mérida, Yucatan, C.P. 97000, México. Phone and fax: 52 999 923-86-73. E-mail: mbzaidi{at}yuc.quik.com.


Antimicrobial Agents and Chemotherapy, June 2003, p. 1999-2001, Vol. 47, No. 6
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.6.1999-2001.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.